Zengqiang Li Selected Research

perfluoro-n-heptanoic acid

1/2021

Perfluoroheptanoic acid induces Leydig cell hyperplasia but inhibits spermatogenesis in rats after pubertal exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zengqiang Li Research Topics

Disease

13	Neoplasms (Cancer) 07/2022 - 01/2013
5	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2016
5	Body Weight (Weight, Body) 06/2021 - 10/2020
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 09/2020 - 06/2019
2	Lymphoma (Lymphomas) 01/2022 - 03/2018
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	Infections 10/2021 - 03/2008
2	Hyperplasia 05/2021 - 01/2021
1	Mycoses (Diseases, Fungus) 10/2021
1	Hypoxia (Hypoxemia) 05/2021
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 11/2020
1	Melanoma (Melanoma, Malignant) 11/2020
1	Mycoplasma Pneumonia 10/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2019
1	Ataxia (Dyssynergia) 01/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2015
1	Fibrosarcoma 02/2015
1	Cardiotoxicity 01/2014
1	Adenocarcinoma 01/2013
1	Bacterial Infections (Bacterial Infection) 03/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
5	Phenol (Carbolic Acid)FDA Link 01/2022 - 03/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2020
3	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2020
3	Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA 05/2021 - 01/2021
3	Anaplastic Lymphoma KinaseIBA 11/2019 - 03/2018
2	Tubulin ModulatorsIBA 01/2022 - 08/2017
2	Phosphotransferases (Kinase)IBA 01/2022 - 03/2018
2	2- methoxy- 5- ((3,4,5- trimethosyphenyl)seleninyl)phenolIBA 01/2022 - 03/2016
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 03/2018
2	Testosterone (Sustanon)FDA Link 06/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2020 - 08/2020
2	TubulinIBA 08/2017 - 02/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2022
1	ceritinibIBA 01/2022
1	triadimefon (triadimenol)IBA 10/2021
1	Antifungal AgentsIBA 10/2021
1	perfluorotridecanoic acidIBA 06/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2021
1	Beclin-1IBA 05/2021
1	perfluoro-n-heptanoic acidIBA 01/2021
1	Corn Oil (Oil, Corn)IBA 01/2021
1	piperidine-ethyl-selenopheneIBA 01/2021
1	tebuconazoleIBA 01/2021
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	EnzymesIBA 01/2021
1	B7-H1 AntigenIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	ZearalenoneIBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	vinclozolinIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020
1	combretastatinIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	WY-135IBA 03/2018
1	CrizotinibIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Ketamine FDA LinkGeneric 01/2018
1	NocodazoleIBA 08/2017
1	A 19IBA 08/2016
1	3- (3- hydroxy- 4- methoxyphenyl)- 4- (3,4,5- trimethoxyphenyl)- 1,2,5- selenadiazoleIBA 02/2015
1	fosbretabulin (combretastatin A4)IBA 02/2015
1	CarbamatesIBA 11/2014
1	indoleIBA 11/2014
1	benzimidazoleIBA 11/2014
1	SeleniumIBA 11/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Dacarbazine (DIC)FDA LinkGeneric 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	deoxyuridine triphosphateIBA 01/2013
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2013
1	2- methoxy- 5- (2- (3,4,5- trimethoxyphenyl)thiophen- 3- yl)anilineIBA 01/2013
1	Immune Sera (Antisera)IBA 03/2008
1	AntigensIBA 03/2008
1	pertactin FDA Link 03/2008

Therapy/Procedure

5	Therapeutics 01/2022 - 08/2017
2	Drug Therapy (Chemotherapy) 07/2022 - 08/2020
2	Immunotherapy 11/2020 - 08/2020